Suppr超能文献

Wig1(p53的一个下游靶点)对突变型亨廷顿蛋白的等位基因特异性调控。

Allele-specific regulation of mutant Huntingtin by Wig1, a downstream target of p53.

作者信息

Kim Sun-Hong, Shahani Neelam, Bae Byoung-Ii, Sbodio Juan I, Chung Youjin, Nakaso Kazuhiro, Paul Bindu D, Sawa Akira

机构信息

Department of Psychiatry and Behavioral Sciences.

Neuroscience Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

Hum Mol Genet. 2016 Jun 15;25(12):2514-2524. doi: 10.1093/hmg/ddw115. Epub 2016 May 19.

Abstract

p53 has been implicated in the pathophysiology of Huntington's disease (HD). Nonetheless, the molecular mechanism of how p53 may play a unique role in the pathology remains elusive. To address this question at the molecular and cellular biology levels, we initially screened differentially expressed molecules specifically dependent on p53 in a HD animal model. Among the candidate molecules, wild-type p53-induced gene 1 (Wig1) is markedly upregulated in the cerebral cortex of HD patients. Wig1 preferentially upregulates the level of mutant Huntingtin (Htt) compared with wild-type Htt. This allele-specific characteristic of Wig1 is likely to be explained by higher affinity binding to mutant Htt transcripts than normal counterpart for the stabilization. Knockdown of Wig1 level significantly ameliorates mutant Htt-elicited cytotoxicity and aggregate formation. Together, we propose that Wig1, a key p53 downstream molecule in HD condition, play an important role in stabilizing mutant Htt mRNA and thereby accelerating HD pathology in the mHtt-p53-Wig1 positive feedback manner.

摘要

p53已被认为与亨廷顿舞蹈症(HD)的病理生理学有关。然而,p53在该疾病病理学中如何发挥独特作用的分子机制仍不清楚。为了在分子和细胞生物学水平上解决这个问题,我们最初在HD动物模型中筛选了特异性依赖p53的差异表达分子。在这些候选分子中,野生型p53诱导基因1(Wig1)在HD患者的大脑皮层中显著上调。与野生型亨廷顿蛋白(Htt)相比,Wig1优先上调突变型Htt的水平。Wig1的这种等位基因特异性特征可能是由于其与突变型Htt转录本的结合亲和力高于正常对应物,从而实现稳定化。敲低Wig1水平可显著改善突变型Htt引发的细胞毒性和聚集体形成。总之,我们认为Wig1是HD条件下p53的关键下游分子,它在稳定突变型Htt mRNA方面发挥重要作用,从而以mHtt-p53-Wig1正反馈方式加速HD病理学进程。

相似文献

1
Allele-specific regulation of mutant Huntingtin by Wig1, a downstream target of p53.
Hum Mol Genet. 2016 Jun 15;25(12):2514-2524. doi: 10.1093/hmg/ddw115. Epub 2016 May 19.
2
Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
J Huntingtons Dis. 2013;2(4):491-500. doi: 10.3233/JHD-130079.
5
Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells.
Sci Rep. 2017 Apr 24;7:46740. doi: 10.1038/srep46740.
6
Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
PLoS One. 2011;6(8):e23837. doi: 10.1371/journal.pone.0023837. Epub 2011 Aug 26.
8
HuR stabilizes mRNA via interacting with its exon 11 in a mutant HTT-dependent manner.
RNA Biol. 2020 Apr;17(4):500-516. doi: 10.1080/15476286.2020.1712894. Epub 2020 Jan 13.

引用本文的文献

1
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.
Int J Mol Sci. 2023 Nov 27;24(23):16798. doi: 10.3390/ijms242316798.
2
Pain in Huntington's disease and its potential mechanisms.
Front Aging Neurosci. 2023 Jul 6;15:1190563. doi: 10.3389/fnagi.2023.1190563. eCollection 2023.
4
Molecular Pathophysiological Mechanisms in Huntington's Disease.
Biomedicines. 2022 Jun 17;10(6):1432. doi: 10.3390/biomedicines10061432.
5
Drug delivery approaches for HuR-targeted therapy for lung cancer.
Adv Drug Deliv Rev. 2022 Jan;180:114068. doi: 10.1016/j.addr.2021.114068. Epub 2021 Nov 22.
7
WIG1 is crucial for AGO2-mediated ACOT7 mRNA silencing via miRNA-dependent and -independent mechanisms.
Nucleic Acids Res. 2017 Jun 20;45(11):6894-6910. doi: 10.1093/nar/gkx307.

本文引用的文献

1
Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts.
Biochemistry. 2013 Nov 19;52(46):8219-25. doi: 10.1021/bi401129r. Epub 2013 Nov 7.
4
Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
Cell Stem Cell. 2012 Aug 3;11(2):253-63. doi: 10.1016/j.stem.2012.04.026. Epub 2012 Jun 28.
6
Reciprocal influence of the p53 and the hypoxic pathways.
Cell Death Dis. 2011 May 26;2(5):e164. doi: 10.1038/cddis.2011.48.
7
Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.
Neuroscientist. 2011 Oct;17(5):475-92. doi: 10.1177/1073858410390378. Epub 2011 Feb 10.
8
Oligonucleotide therapeutic approaches for Huntington disease.
J Clin Invest. 2011 Feb;121(2):500-7. doi: 10.1172/JCI45130. Epub 2011 Feb 1.
9
Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
Nucleic Acids Res. 2011 May;39(9):3852-63. doi: 10.1093/nar/gkq1323. Epub 2011 Jan 18.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验